Clinical Trial Update: DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax [Phase 2]

View source ↗

Summary

A Phase IIa study of the malaria candidate DSM265 for Plasmodium falciparum and Plasmodium vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• DSM265

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria | Phase 2 | Status: COMPLETED